Market Overview

Aimmune Therapeutics (NASDAQ: AIMT)

22.91 +0.30 (1.33%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/13/18Goldman SachsInitiates Coverage OnNeutral32.0
12/03/18Cantor FitzgeraldAssumesOverweight64.0
9/14/18Stifel NicolausInitiates Coverage OnHold33.0
8/13/18Credit SuisseMaintainsOutperform40.0
3/05/18Credit SuisseMaintainsOutperform47.0
2/07/18RBC CapitalInitiates Coverage OnOutperform55.0
12/20/17BairdInitiates Coverage OnOutperform64.0
12/13/17Cantor FitzgeraldInitiates Coverage OnOverweight55.0
10/23/17Credit SuisseMaintainsOutperform45.0
3/07/16Credit SuisseMaintainsOutperform35.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter